Detailed Cancer Screening
with Liquid Biopsy

Detect and Monitor Cancer Early with Advanced Genetic Testing
Test Description

Universal Cancer Screening (Liquid Biopsy)

Express Gene™ Universal Cancer Screening utilizes liquid biopsy technology to provide a comprehensive genetic analysis for the early detection and monitoring of cancer. This non-invasive test analyzes circulating tumor DNA (ctDNA) in your blood, allowing for the identification of genetic mutations associated with various types of cancer. By detecting cancer at its earliest stages, this test empowers you with critical information to take proactive steps in managing your health and treatment.

Discover the Advantages

Unlock the Benefits of
Universal Cancer Screening

Early Detection

Identify cancer at its earliest and most treatable stages, significantly improving the chances of successful treatment.

Comprehensive Coverage

Screen for multiple types of cancer simultaneously, offering a broad assessment of your cancer risk.

Personalized Treatment

Gain insights into specific genetic mutations, allowing for tailored treatment plans that target the unique characteristics of your cancer.

Genes Analyzed

Explore the Genetic Markers Included in Our Cancer Genetic Testing Panel

CODIS Markers

ACP5, ADA2, ADAM17, ADAR, AP1S3, ASAH1, CARD14, COPA, DDX58, ELANE, HAX1, HTR1A, IFIH1, IL10RA, IL10RB, IL1RN, IL36RN, ISG15, LPIN2, MEFV, MVK, NLRC4, NLRP1, NLRP12, NLRP3, NOD2, OTULIN, PIK3CD, PIK3R1, PLCG2, POLA1, POMP, PRG4, PRKCD, PSENEN, PSMA3, PSMB4, PSMB8, PSMG2, PSTPIP1, RBCK1, RIPK1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, SH3BP2, SLC29A3, TMEM173, TNFAIP3, TNFRSF11A, TNFRSF1A, TREX1, TRNT1, USP18, WDR1 

Getting Started with
Universal Cancer Screening

Ensure early detection and personalized cancer care with Express Gene™ Universal Cancer Screening.

Start Your Journey to Better Health